Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

The death of a Scottish nurse as a result of complications after taking the drug Mounjaro for weight loss has highlighted the potential dangers ...

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

Both Wegovy and Mounjaro have now been approved for treating obesity on the NHS, and the Government has announced ambitious plans to offer them to thousands of people who are unable to work with ...

The latest incidence of this in the UK came last week, when health secretary Wes Streeting announced that drugs like Wegovy or Mounjaro could be given to unemployed people to help them get back ...

Novo Nordisk, the drug company that makes Ozempic and Wegovy, and Eli Lilly, the manufacturer of Mounjaro and Zepbound, do not deny that their drugs cause side effects, most often involving GI ...

The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...